Financial analysis of Pfizer Inc. stock ahead of its earnings release. PFE faces significant headwinds from patent expiries, click for my updated look at the stock.

Pfizer PFE will report its fourth-quarter and full-year 2024 earnings on Feb. 4, before market open. The Zacks Consensus ...

Pfizer said it will 'support capacity-building initiatives, such as training healthcare professionals and advancing clinical ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a ...

RSV is a contagious virus causing severe respiratory infections in infants. Vaccination during pregnancy, provides newborns with maternal antibodies, reducing severe RSV cases by 70% in their first ...

Taking simple yet effective preventative measures can significantly reduce the risk of illness and help keep you and your ...

About 8 in 10 infants received respiratory syncytial virus protection during the 2023 to 2024 season, according to study findings.

Jason McLellan, professor in the Department of Molecular Biosciences and Robert A. Welch Chair in Chemistry at UT, will be ...